Massive study aims to map hepatitis c elimination in pakistan

NCT ID NCT04943588

Completed Knowledge-focused Sponsor: Queen Mary University of London Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This large study in Pakistan tracks 25,000 adults with hepatitis C to see how well current government-sponsored treatments work and whether the virus develops resistance. Researchers will measure cure rates, new infections, and reinfections over time. The goal is to find the best strategies to eliminate hepatitis C in the country.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could identify the most effective ways to treat and prevent hepatitis C in large populations, moving toward eliminating the virus in Pakistan.
What could go wrong: This is an observational study, not a test of a new drug, so it won't directly produce a new treatment. Results may also vary in other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis C virus infection hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATITIS C, CHRONIC

Contacts and locations

Show contact details

Locations

Aga Khan University

Karachi, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.